Cancer Research UK logo.
SearchDonate
  • Search

A trial of plitidepsin with dexamethasone for myeloma that has come back or is no longer responding to treatment (ADMYRE)

Overview

Cancer types:

Blood cancers, Myeloma

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at dexamethasone and plitidepsin for myeloma that is not responding to treatment or has come back after other types of treatment. You may hear this called refractory or relapsed myeloma.

Recruitment start: 1 June 2010

Recruitment end: 31 May 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Amin Rahemtulla

Supported by

Pharma Mar

Hammersmith Hospital

Last reviewed: 18 December 2015

CRUK internal database number: 7877

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.